Metavia Stock Performance
| MTVA Stock | 1.60 0.16 9.09% |
The company secures a Beta (Market Risk) of 2.89, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, MetaVia will likely underperform. At this point, MetaVia has a negative expected return of -0.95%. Please make sure to verify MetaVia's kurtosis, as well as the relationship between the day median price and period momentum indicator , to decide if MetaVia performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days MetaVia has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors. ...more
1 | NeuroBo rebrands to MetaVia, changes Nasdaq ticker to MTVA - Investing.com | 11/18/2024 |
2 | Neurobo Pharmaceuticals, Inc. Announces Management Changes - Marketscreener.com | 11/29/2024 |
3 | MetaVia to Present at the Emerging Growth Conference in December | 12/02/2024 |
4 | Disposition of 2867 shares by Kim Hyung Heon of MTVA at 2.55 subject to Rule 16b-3 | 12/04/2024 |
5 | NeuroBo Pharmaceuticals versus InterCure Head to Head Review | 12/19/2024 |
6 | MTVA Compelling Data for DA-1241 in Phase 2a MASH Trial | 12/20/2024 |
MetaVia |
MetaVia Relative Risk vs. Return Landscape
If you would invest 320.00 in MetaVia on September 24, 2024 and sell it today you would lose (160.00) from holding MetaVia or give up 50.0% of portfolio value over 90 days. MetaVia is currently does not generate positive expected returns and assumes 5.0206% risk (volatility on return distribution) over the 90 days horizon. In different words, 44% of stocks are less volatile than MetaVia, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
MetaVia Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for MetaVia's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as MetaVia, and traders can use it to determine the average amount a MetaVia's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1896
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | MTVA |
Estimated Market Risk
| 5.02 actual daily | 44 56% of assets are more volatile |
Expected Return
| -0.95 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.19 actual daily | 0 Most of other assets perform better |
Based on monthly moving average MetaVia is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of MetaVia by adding MetaVia to a well-diversified portfolio.
About MetaVia Performance
By analyzing MetaVia's fundamental ratios, stakeholders can gain valuable insights into MetaVia's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if MetaVia has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if MetaVia has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
MetaVia is entity of United States. It is traded as Stock on NASDAQ exchange.Things to note about MetaVia performance evaluation
Checking the ongoing alerts about MetaVia for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for MetaVia help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| MetaVia generated a negative expected return over the last 90 days | |
| MetaVia has high historical volatility and very poor performance | |
| MetaVia may become a speculative penny stock | |
| MetaVia was previously known as Neurobo Pharmaceuticals and was traded on NASDAQ Exchange under the symbol NRBO. | |
| Latest headline from finance.yahoo.com: MTVA Compelling Data for DA-1241 in Phase 2a MASH Trial |
- Analyzing MetaVia's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether MetaVia's stock is overvalued or undervalued compared to its peers.
- Examining MetaVia's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating MetaVia's management team can have a significant impact on its success or failure. Reviewing the track record and experience of MetaVia's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of MetaVia's stock. These opinions can provide insight into MetaVia's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for MetaVia Stock analysis
When running MetaVia's price analysis, check to measure MetaVia's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MetaVia is operating at the current time. Most of MetaVia's value examination focuses on studying past and present price action to predict the probability of MetaVia's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MetaVia's price. Additionally, you may evaluate how the addition of MetaVia to your portfolios can decrease your overall portfolio volatility.
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |